JP6756612B2 - キレーターを含む微粒子化した胎盤性組成物 - Google Patents

キレーターを含む微粒子化した胎盤性組成物 Download PDF

Info

Publication number
JP6756612B2
JP6756612B2 JP2016537863A JP2016537863A JP6756612B2 JP 6756612 B2 JP6756612 B2 JP 6756612B2 JP 2016537863 A JP2016537863 A JP 2016537863A JP 2016537863 A JP2016537863 A JP 2016537863A JP 6756612 B2 JP6756612 B2 JP 6756612B2
Authority
JP
Japan
Prior art keywords
composition
tissue
placental
amniotic membrane
components
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016537863A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016529286A5 (OSRAM
JP2016529286A (ja
Inventor
ジェー． クーブ，トーマス
ジェー． クーブ，トーマス
Original Assignee
ミメディクス グループ インコーポレイテッド
ミメディクス グループ インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ミメディクス グループ インコーポレイテッド, ミメディクス グループ インコーポレイテッド filed Critical ミメディクス グループ インコーポレイテッド
Publication of JP2016529286A publication Critical patent/JP2016529286A/ja
Publication of JP2016529286A5 publication Critical patent/JP2016529286A5/ja
Application granted granted Critical
Publication of JP6756612B2 publication Critical patent/JP6756612B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/547—Chelates, e.g. Gd-DOTA or Zinc-amino acid chelates; Chelate-forming compounds, e.g. DOTA or ethylenediamine being covalently linked or complexed to the pharmacologically- or therapeutically-active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2016537863A 2013-08-30 2014-08-28 キレーターを含む微粒子化した胎盤性組成物 Active JP6756612B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361872393P 2013-08-30 2013-08-30
US61/872,393 2013-08-30
PCT/US2014/053270 WO2015031681A1 (en) 2013-08-30 2014-08-28 Micronized placental compositions comprising a chelator

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019095806A Division JP2019172681A (ja) 2013-08-30 2019-05-22 キレーターを含む微粒子化した胎盤性組成物

Publications (3)

Publication Number Publication Date
JP2016529286A JP2016529286A (ja) 2016-09-23
JP2016529286A5 JP2016529286A5 (OSRAM) 2017-10-05
JP6756612B2 true JP6756612B2 (ja) 2020-09-16

Family

ID=52583586

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016537863A Active JP6756612B2 (ja) 2013-08-30 2014-08-28 キレーターを含む微粒子化した胎盤性組成物
JP2019095806A Pending JP2019172681A (ja) 2013-08-30 2019-05-22 キレーターを含む微粒子化した胎盤性組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019095806A Pending JP2019172681A (ja) 2013-08-30 2019-05-22 キレーターを含む微粒子化した胎盤性組成物

Country Status (4)

Country Link
US (2) US10449220B2 (OSRAM)
EP (1) EP3038630B1 (OSRAM)
JP (2) JP6756612B2 (OSRAM)
WO (1) WO2015031681A1 (OSRAM)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10517931B2 (en) 2013-01-17 2019-12-31 Mimedx Group, Inc. Non-surgical, localized delivery of compositions for placental growth factors
US9827293B2 (en) 2013-01-17 2017-11-28 Mimedx Group, Inc. Non-surgical, localized delivery of compositions for placental growth factors
US9655948B1 (en) 2013-01-17 2017-05-23 Mimedx Group, Inc. Non-surgical, localized delivery of compositions for placental growth factors
WO2015038477A1 (en) * 2013-09-10 2015-03-19 Mimedx Group, Inc. Cosmetic uses of molded placental compositions
EP3167049A4 (en) * 2014-07-08 2017-11-29 MIMEDX Group Inc. Micronized wharton's jelly
US10736990B2 (en) 2015-02-11 2020-08-11 Mimedx Group, Inc. Collagen and micronized placental tissue compositions and methods of making and using the same
US9603967B2 (en) 2015-05-08 2017-03-28 Vivex Biomedical, Inc. Placental tissue assembly
MA45272A (fr) * 2015-06-27 2018-05-02 Stimlabs Llc Produits issus de liquide amniotique et procédés d'utilisation
WO2017041089A1 (en) * 2015-09-03 2017-03-09 Mimedx Group, Inc. Non-surgical, localized delivery of compositions for placental growth factors
WO2019220421A1 (en) 2018-05-18 2019-11-21 Mimedx Group, Inc. Placental tissue component compositions for treatment of skin defects and methods using same

Family Cites Families (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2303529A1 (fr) * 1975-03-10 1976-10-08 Florent Joseph Procede de fixation de metaux et de metalloides sur du placenta et autres tissus d'origine animale, et produits obtenus pouvant etre utilises a la preparation de produits cosmetiques
CA1295796C (en) 1984-03-27 1992-02-18 Conrad Whyne Biodegradable matrix and methods for producing same
US4895727A (en) 1985-05-03 1990-01-23 Chemex Pharmaceuticals, Inc. Pharmaceutical vehicles for exhancing penetration and retention in the skin
WO1987000062A1 (en) 1985-07-02 1987-01-15 Target Therapeutics Vaso-occlusive collagen composition and method
US4847049A (en) 1985-12-18 1989-07-11 Vitaphore Corporation Method of forming chelated collagen having bactericidal properties
EP0290442A4 (en) 1986-11-19 1990-07-03 Chemex Pharmaceuticals Inc MEDICINAL PREPARATIONS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS.
DD289135A5 (de) 1989-11-16 1991-04-18 Adw Zi F. Molekularbiologie,De Verfahren zur bestimmung reduzierender oder oxidierender stoffe
JPH03176064A (ja) 1989-12-05 1991-07-31 Hoechst Japan Ltd 創面被覆材
JPH0427352A (ja) * 1990-05-22 1992-01-30 Fuji Capsule Kk 健康食品用腸溶性軟カプセル
US5409690A (en) 1993-06-23 1995-04-25 Chemex Pharmaceuticals, Inc. Treatment of multidrug resistant diseases in cancer cell by potentiating with masoprocol
CA2140053C (en) 1994-02-09 2000-04-04 Joel S. Rosenblatt Collagen-based injectable drug delivery system and its use
US7101857B2 (en) 1996-11-05 2006-09-05 Gp Medical, Inc. Crosslinkable biological material and medical uses
US6166184A (en) 1997-08-18 2000-12-26 Medtronic Inc. Process for making a bioprosthetic device
US6129757A (en) 1998-05-18 2000-10-10 Scimed Life Systems Implantable members for receiving therapeutically useful compositions
CN100544704C (zh) 1999-06-25 2009-09-30 宝洁公司 局部抗微生物组合物
US6716895B1 (en) 1999-12-15 2004-04-06 C.R. Bard, Inc. Polymer compositions containing colloids of silver salts
US6682760B2 (en) 2000-04-18 2004-01-27 Colbar R&D Ltd. Cross-linked collagen matrices and methods for their preparation
US6565960B2 (en) 2000-06-01 2003-05-20 Shriners Hospital Of Children Polymer composite compositions
AU2001288025A1 (en) 2000-09-05 2002-03-22 Biosight Ltd. Peptide conjugated anti-cancer prodrugs
US6503244B2 (en) 2001-03-07 2003-01-07 Micro Therapeutics, Inc. High pressure injection system
WO2003032735A1 (en) 2001-10-18 2003-04-24 Lifecell Corporation Remodeling of tissues and organs
US20030187515A1 (en) 2002-03-26 2003-10-02 Hariri Robert J. Collagen biofabric and methods of preparing and using the collagen biofabric
US20050142161A1 (en) 2003-12-30 2005-06-30 Freeman Lynetta J. Collagen matrix for soft tissue augmentation
US7405037B2 (en) 2004-05-07 2008-07-29 Lonza Walkersville, Inc. Methods and tools for detecting collagen degradation
US7794490B2 (en) 2004-06-22 2010-09-14 Boston Scientific Scimed, Inc. Implantable medical devices with antimicrobial and biodegradable matrices
AU2006257878A1 (en) 2005-06-10 2006-12-21 Celgene Corporation Human placental collagen compositions, processes for their preparation, methods of their use and kits comprising the compositions
WO2007009061A2 (en) 2005-07-13 2007-01-18 Anthrogenesis Corporation Ocular plug formed from placenta derived collagen biofabric
US20070299043A1 (en) 2005-10-03 2007-12-27 Hunter William L Anti-scarring drug combinations and use thereof
AU2006304908B2 (en) 2005-10-18 2012-03-22 Organogenesis, Inc. Antimicrobial collagenous constructs
EP1973952A4 (en) 2006-01-23 2010-09-01 Kwangju Inst Sci & Tech CONJUGATE COMPRISING A COVALENT TO A MUCOADHESIVE POLYMER-ASSOCIATED PHARMACEUTICALLY ACTIVE COMPOUND, AND A TRANSMUCOSAL ADMINISTRATION METHOD FOR A PHARMACEUTICALLY ACTIVE COMPOUND USING THEREOF
WO2007103555A2 (en) 2006-03-08 2007-09-13 Nuviance, Inc. Transdermal drug delivery compositions and topical compositions for application on the skin
US20070248575A1 (en) 2006-04-19 2007-10-25 Jerome Connor Bone graft composition
US7993918B2 (en) 2006-08-04 2011-08-09 Anthrogenesis Corporation Tumor suppression using placental stem cells
US8105634B2 (en) 2006-08-15 2012-01-31 Anthrogenesis Corporation Umbilical cord biomaterial for medical use
US8372437B2 (en) 2006-08-17 2013-02-12 Mimedx Group, Inc. Placental tissue grafts
WO2008060377A2 (en) * 2006-10-04 2008-05-22 Anthrogenesis Corporation Placental or umbilical cord tissue compositions
EP2076279B1 (en) 2006-10-06 2014-08-27 Anthrogenesis Corporation Native (telopeptide) placental collagen compositions
US20100028849A1 (en) 2006-10-18 2010-02-04 Nancy Jane Shelby Novel process for devitalized/acellular tissue for transplantation
US8177839B2 (en) 2006-12-27 2012-05-15 Shriners Hospitals For Children Woven and/or braided fiber implants and methods of making same
EP2131880B1 (en) 2007-02-20 2012-08-08 Shriners Hospitals for Children In vivo hydraulic fixation including bio-rivets using biocompatible expandable fibers
US20080233552A1 (en) 2007-03-22 2008-09-25 David Hui-Kang Ma Method of cross-linking amnion to be an improved biomedical material
EP3473260B1 (en) 2007-07-10 2020-09-23 LifeCell Corporation Acellular tissue matrix compositions for tissue repair
CA2736663C (en) * 2007-09-07 2018-01-02 Surgical Biologics, Llc. Placental tissue grafts and improved methods of preparing and using the same
US20100317677A1 (en) 2007-09-11 2010-12-16 Hassel Bret A Methods of Treating a Microbial Infection by Modulating RNase-L Expression and/or Activity
AU2008307633C1 (en) 2007-09-28 2015-04-30 Celularity Inc. Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
WO2009048780A1 (en) 2007-10-08 2009-04-16 The University Of Kentucky Research Foundation Polymer-metal chelator conjugates and uses thereof
JP5492097B2 (ja) 2008-02-22 2014-05-14 マイメディクス，インコーポレイテッド 手首、手及びその他の靱帯置換術又は修復術のために適切なバイオステープル
CA2722475A1 (en) 2008-04-25 2009-10-29 Allosource Anti-adhesion barrier wound dressing comprising processed amniotic tissue and method of use
US9694055B2 (en) 2008-05-09 2017-07-04 Wake Forest University Health Sciences Renal tissue regeneration
EP2291143B1 (en) 2008-05-16 2020-07-08 Mimedx, Inc. Medical constructs of twisted lengths of collagen fibers and methods of making same
GB0816496D0 (en) 2008-09-10 2008-10-15 Zhao Xiaobin Hyaluronic acid cryogel
CA2740008C (en) 2008-10-09 2017-01-31 Mimedx, Inc. Methods of making biocomposite medical constructs and related constructs including artificial tissues, vessels and patches
US20100291182A1 (en) 2009-01-21 2010-11-18 Arsenal Medical, Inc. Drug-Loaded Fibers
EP2393854B1 (en) 2009-02-04 2019-12-04 The Brigham and Women's Hospital, Inc. Nanoscale platinum compounds and methods of use thereof
US20110212158A1 (en) 2010-02-18 2011-09-01 Samson Tom Immunocompatible chorionic membrane products
CA2798712C (en) 2010-05-17 2018-07-17 Mimedx, Inc. Compressible tubes for placing implants and related medical kits and methods of using same
US20120010708A1 (en) 2010-07-08 2012-01-12 AFcell Medical Amnion and chorion replacement cover and uses thereof in surgical repair of muscles
WO2012065937A1 (en) 2010-11-15 2012-05-24 Novartis Forschungsstiftung, Zweigniederlassung, Friedrich Miescher Institute For Biomedical Research Anti-fungal agents
EP2458043A1 (en) 2010-11-24 2012-05-30 SpinPlant GmbH Product of crosslinked material and method for producing the same
US20120189586A1 (en) * 2011-01-21 2012-07-26 Carl Randall Harrell Human Placental Derived Extracellular Matrix and Uses Therof
EP3744336B1 (en) 2011-02-14 2025-01-01 MiMedx Group, Inc. Micronized placental tissue compositions and methods for making and using the same
US10350049B2 (en) 2011-02-14 2019-07-16 Mimedx Group, Inc. Laminated tissue grafts composed of Wharton's jelly and methods of making and using the same
EP2675465B1 (en) 2011-02-14 2020-07-01 MIMEDX Group Inc. Tissue grafts modified with a cross-linking agent and method of making and using the same
AU2012217975B2 (en) 2011-02-14 2015-11-19 Mimedx Group Inc. Micronized placental tissue compositions and methods for making and using the same
CA2829339C (en) 2011-03-08 2018-10-16 Mimedx, Inc. Collagen fiber ribbons with integrated fixation sutures and methods of making the same
US9327029B2 (en) 2011-05-05 2016-05-03 Celacare Technologies, Llc Antimicrobial silver hydrogel composition for the treatment of burns and wounds
CA2857636C (en) 2011-12-22 2020-06-23 Mimedx Group Inc. Cross-linked dehydrated placental tissue grafts and methods for making and using the same
US9943551B2 (en) 2012-08-15 2018-04-17 Mimedx Group, Inc. Tissue grafts composed of micronized placental tissue and methods of making and using the same
US11338063B2 (en) 2012-08-15 2022-05-24 Mimedx Group, Inc. Placental tissue grafts modified with a cross-linking agent and methods of making and using the same
WO2014028657A1 (en) 2012-08-15 2014-02-20 Mimedx Group, Inc Reinforced placental tissue grafts and methods of making and using the same
US8904664B2 (en) 2012-08-15 2014-12-09 Mimedx Group, Inc. Dehydration device and methods for drying biological materials
EP2897625B1 (en) 2012-09-10 2019-10-23 Wake Forest University Health Sciences Amniotic membrane and its use in wound healing and tissue engineering constructs
US20140106447A1 (en) 2012-10-12 2014-04-17 Mimedx Group, Inc. Compositions and methods for recruiting stem cells
US8946163B2 (en) 2012-11-19 2015-02-03 Mimedx Group, Inc. Cross-linked collagen comprising metallic anticancer agents
US9155799B2 (en) 2012-11-19 2015-10-13 Mimedx Group, Inc. Cross-linked collagen with at least one bound antimicrobial agent for in vivo release of the agent
US8940684B2 (en) 2012-11-19 2015-01-27 Mimedx Group, Inc. Cross-linked collagen comprising an antifungal agent
US10029030B2 (en) 2013-03-15 2018-07-24 Mimedx Group, Inc. Molded placental tissue compositions and methods of making and using the same
US10335433B2 (en) 2013-04-10 2019-07-02 Mimedx Group, Inc. NDGA polymers and metal complexes thereof
US9446142B2 (en) * 2013-05-28 2016-09-20 Mimedx Group, Inc. Polymer chelator conjugates

Also Published As

Publication number Publication date
US20150064274A1 (en) 2015-03-05
EP3038630A4 (en) 2017-05-03
EP3038630B1 (en) 2020-03-18
EP3038630A1 (en) 2016-07-06
WO2015031681A9 (en) 2015-09-24
US20190381107A1 (en) 2019-12-19
JP2019172681A (ja) 2019-10-10
US12076348B2 (en) 2024-09-03
US10449220B2 (en) 2019-10-22
JP2016529286A (ja) 2016-09-23
WO2015031681A1 (en) 2015-03-05

Similar Documents

Publication Publication Date Title
JP6756612B2 (ja) キレーターを含む微粒子化した胎盤性組成物
US10842824B2 (en) Method for inducing angiogenesis
JP7304316B2 (ja) 微粉化ホウォートンゼリー
US12070528B2 (en) Collagen and micronized placental tissue compositions and methods of making and using the same
US11389565B2 (en) Molded placental tissue compositions and methods of making and using the same
JP6640826B2 (ja) 微粒子化ワルトン膠質
JP2016529070A (ja) 成形胎盤組成物の美容的使用
Rayat Pisheh et al. Amniotic membrane, a novel bioscaffold in cardiac diseases: from mechanism to applications
Alibabaei-Omran et al. Viewing Decellularized Amniotic Membrane Through the Lens of Coupled Scaffolding and Drug Delivery Systems in Regenerative Medicine
US11497791B1 (en) Isolated placental stem cell recruiting factors

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170825

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170825

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180424

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180723

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180919

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20181023

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20190122

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190522

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20190712

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20190802

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20200827

R150 Certificate of patent or registration of utility model

Ref document number: 6756612

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250